Skip to main content

Global Dialysis Market Size Worth USD 177.56 Billion at 7.7% CAGR; Key Market Leaders Such as Fresenius and Baxter to Focus on Efficient Delivery of Dialysis Services to Patients: Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Jan. 21, 2021 (GLOBE NEWSWIRE) — The global dialysis market size is projected to reach USD 177.56 billion by 2027, exhibiting a CAGR of 7.7% during the forecast period. Complications caused in the renal system by the COVID-19 infection is likely to spike the demand for dialysis during the current year, states Fortune Business Insights™ in its report.The COVID-19 infection, according to researchers at the Johns Hopkins University, has been affecting kidney function in patients, even among those who have no history of kidney disease or any underlying renal condition. The university’s preliminary reports found that around 30% of the coronavirus patients in New York and China suffered from moderate to severe kidney malfunction during their hospital stay.KEY INDUSTRY DEVELOPMENTS:October 2019 – The USFDA granted breakthrough device designation to a new hemodialysis system by Fresenius Medical Care. The product, which is currently in development, aims to prevent blood clotting without the use of blood thinners in most patients.August 2017 – B. Braun Medical Inc. announced that it has received USFDA clearance for its hemodialyzer, Diacap Pro. Its advances in fiber technology provide a lower comparable surface area and an increased molecule-to-surface contact.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dialysis-market-102367
Rising Preference for Kidney Transplantation to Hamper Market GrowthPatients around the world suffering from kidney disease or damage are showing an increasing inclination towards kidney transplantation. The Global Observatory on Donation and Transplantation reported that 84,347 kidney transplant procedures were performed across the globe, indicating a 5.5% rise from 2014 levels. Similarly, the US Government Information on Organ Donation and Transplantation estimated that there were over 116,000 patients on the national transplant waiting list in August 2017.This preference for transplantation over dialysis procedures is mainly on account of the promise of better quality life and lower risk of death in end-stage kidney disease patients. On the other hand, dialysis requires hours of treatment at hospital or a clinic; with patients reporting low blood pressure, nausea, and abdominal cramps after the procedure was completed. To avoid the inconvenience and pain caused by dialysis, kidney patients increasingly prefer getting a new kidney, which bodes well for the dialysis market growth.
Click here to get the short-term and long-term impacts of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/dialysis-market-102367
North America to Hold Dominating Position in the Market; Asia-Pacific to Offer Bright ProspectsHigh incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) enabled North America to register a market size of USD 36.46 billion in 2019. In 2020, the region is expected to tighten its hold on the market share owing to the skyrocketing number of COVID-19 cases in the US, which is surging the demand for these services in the region.In Asia-Pacific, on the other hand, the market stands to benefit considerably on account of rising government funding in India and China to enhance access to renal care. For instance, China formulated specific regulations in 2016 to establish standards for managing hemodialysis centers in the country. The market in Europe is also anticipated to grow steadily owing to the robust healthcare infrastructure in the continent.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dialysis-market-102367
Regulatory Backing to Novel Products to Encourage Innovation among PlayersDevelopment of innovative dialysis solutions has been the mainstay strategy of majority of the players in this market. These innovations are finding strong support from regulatory bodies such as the US Food and Drug Administration (FDA), which is further encouraging other players to invest in R&D and bring out unique solutions for kidney patients.List of Players Covered in this Market Report:•          Nipro Corporation•          Medtronic•          Becton, Dickinson and Company•          B. Braun Melsungen AG•          Fresenius Medical Care AG & Co. KGaA •          Asahi Kasei Corporation•          Diaverum Healthcare Partners•          Baxter International, Inc.•          DaVita Healthcare Partners, Inc.
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/dialysis-market-102367
Market Segmentations:By Type•              Products•              ServicesBy Dialysis Type•              Hemodialysis•              Peritoneal DialysisBy End User•              Dialysis Centers & Hospitals•              Home Care By Geography•              North America (U.S. and Canada)•              Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)•              Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia-Pacific)•              Latin America (Brazil, Mexico, and Rest of Latin America)•              Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companiesDetails in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facilityNumber of procedures and average price of proceduresReplacement rate and pricing of capital equipmentMarket dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunitiesMarket & technological trends, new product developments, product pipeline.
Quick Buy –  Dialysis Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102367
Have a Look at Related Reports:Anticoagulants Market Share & Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026Germany Pneumococcal Vaccines Market Share & Industry Analysis, By Product Type (PCV10, PCV13, and PPSV23), By End User (Hospitals, Clinics, and Others) and Region Forecast, 2019-2026Preeclampsia Diagnostics Market Share & Industry Analysis, By Test Type (Blood Tests and Urine Analysis), By Product (Instruments and Consumables) End-user (Hospitals, Specialty Clinics, Diagnostic Centers, and Others) and Regional Forecast, 2019-2026Assisted Reproductive Technology (ART) Market Share & Industry Analysis, By Technique (In-Vitro Fertilization (IVF), Artificial Insemination (AI-IUI), Frozen Embryo Transfer (FET), and Others), By Procedure (Fresh Donor, Fresh Non-donor, Frozen Donor, and Frozen Non-donor), By End User (Fertility Clinics, and Hospitals) and Regional Forecast, 2019-2026Nuclear Medicine/ Radiopharmaceuticals Market Share & Industry Analysis, By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals & Clinics, Diagnostic Centers, and Others) and Regional Forecast, 2019-2026
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/dialysis-market-9627

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.